![]() |
Volumn 35, Issue 4, 2012, Pages 255-256
|
Inadequate reporting of concomitant drug treatment in cardiovascular interventional head-to-head trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ANGINA PECTORIS;
CORONARY ARTERY BYPASS GRAFT;
FOLLOW UP;
HEART SURGERY;
HUMAN;
INTERMETHOD COMPARISON;
PERCUTANEOUS CORONARY INTERVENTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
SYSTEMATIC REVIEW;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ANGIOPLASTY, BALLOON, CORONARY;
CORONARY ARTERY BYPASS;
CORONARY ARTERY DISEASE;
EVIDENCE-BASED MEDICINE;
HUMANS;
INFORMATION DISSEMINATION;
RISK ASSESSMENT;
SECONDARY PREVENTION;
TIME FACTORS;
|
EID: 84859764890
PISSN: 01609289
EISSN: 19328737
Source Type: Journal
DOI: 10.1002/clc.21958 Document Type: Review |
Times cited : (7)
|
References (7)
|